• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel discussion: Preemptive Medicine from the Perspective of Physicians: Lung Cancer].

作者信息

Hagiwara Koichi

出版信息

Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1808-11.

PMID:30160874
Abstract
摘要

相似文献

1
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel discussion: Preemptive Medicine from the Perspective of Physicians: Lung Cancer].
Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1808-11.
2
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel discussion: Preemptive Strategies in Internal Medicine: Introduction].
Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1802.
3
Medicine. Why a new cancer drug works well, in some patients.医学。为何一种新型抗癌药物在部分患者身上疗效良好。
Science. 2004 Apr 30;304(5671):658-9. doi: 10.1126/science.304.5671.658a.
4
The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy.表皮生长因子受体突变对肺癌治疗反应的影响。
Nat Clin Pract Oncol. 2004 Nov;1(1):2-3. doi: 10.1038/ncponc0007.
5
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel discussion: Preemptive Medicine for Diabetes Mellitus].
Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1803-7.
6
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel discussion: Preemptive Medicine Based on Fetal Programming].[日本内科学会第112届科学会议：会长演讲：小组讨论：基于胎儿编程的预防医学]
Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1825-30.
7
Gefitinib. Still no convincing results in non-small cell lung cancer.吉非替尼。在非小细胞肺癌治疗中仍未取得令人信服的结果。
Prescrire Int. 2010 Jun;19(107):113.
8
Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.多发性骨髓瘤中的罕见病例及转移性肺癌中的显著反应：病例4。一名患有晚期、对吉非替尼敏感的非小细胞肺癌老年男性的表皮生长因子受体突变。
J Clin Oncol. 2005 Jan 1;23(1):235-7. doi: 10.1200/JCO.2005.07.169.
9
Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene.表皮生长因子受体基因存在L833V和H835L杂合复合突变的肺腺癌患者对吉非替尼反应良好。
J Clin Oncol. 2011 Jun 1;29(16):e468-9. doi: 10.1200/JCO.2010.33.5802. Epub 2011 Mar 21.
10
Current status and study activity of lung cancer in Japan.日本肺癌的现状与研究动态
Respir Investig. 2014 Nov;52(6):315-6. doi: 10.1016/j.resinv.2014.10.001. Epub 2014 Oct 22.